Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative neoplasms or myelodysplastic syndromes. The list includes generic and brand names. This page also lists common drug combinations used in myeloproliferative neoplasms or myelodysplastic syndromes. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.

The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in myeloproliferative neoplasms or myelodysplastic syndromes that are not listed here.

Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes

Drug Combinations Used in Myeloproliferative Neoplasms or Myelodysplastic Syndromes

Email